1-2 of 2
Ainslee Moore
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Functional high-risk Relapsed/Refractory multiple myeloma (RRMM) outcomes with belantamab mafodotin (belamaf): Dreamm-7 and dreamm-8 subgroup analysis

Free
María-Victoria Mateos, Vania Hungria, Meral Beksac, Pawel Robak, Kihyun Kim, Sergei Voloshin, Hanlon Sia, Esther González García, Gracia Martinez, Chang-Ki Min, Marcelo Pitombeira de Lacerda, Anna Sureda Balarí, Ivan Špička, Sosana Delimpasi, Marek Hus, Vera Zherebtsova, Christopher Ward, Phoebe Joy Ho, Roman Hajek, Sebastian Grosicki, Syed Zafar, Al-Ola Abdallah, Jorge Mouro, Zeyad Khalaf, Hena Baig, Ainslee Moore, Chee Paul Lin, Maureen Nichols, Ianire Garrobo-Calleja, Sybil Varghese, Nick Pirooz, Joe Lee, Lydia Eccersley, Elisabet Manasanch, Ludek Pour, Meletios Dimopoulos
Journal: Blood
Blood (2025) 146 (Supplement 1): 5820.
https://doi.org/10.1182/blood-2025-5820
Published: 2025
Journal Articles

Deep responses and durable outcomes in patients treated with belantamab mafodotin plus pomalidomide and dexamethasone from long-term follow-up of the Phase 3 dreamm-8 study

Free
Suzanne Trudel, Meral Beksac, Ludek Pour, Sosana Delimpasi, Vladimir Vorobyev, Hang Quach, Ivan Špička, Jakub Radocha, Pawel Robak, Kihyun Kim, Michele Cavo, Kazuhito Suzuki, Syed Zafar, Ainslee Moore, Marie Duggan, Kristin Morris, Amy Phillips-Jones, Margaret Polinkovsky, Joanna Grams, Ianire Garrobo-Calleja, Elisabet Manasanch, Brandon Kremer, Joanna Opalinska, María-Victoria Mateos, Meletios Dimopoulos
Journal: Blood
Blood (2025) 146 (Supplement 1): 2264.
https://doi.org/10.1182/blood-2025-2264
Published: 2025